zurück

ATMP

#

ATMPs in Germany - Strimvelis®

05.06.2024
Strimvelis® (autologous CD34+ cells that contain human adenosine deaminase (ADA) cDNA)...
#

ATMPs in Germany - Imlygic®

30.05.2024
Imlygic was the first ATMP, which reimbursement price was set by the arbitration board after HTA...
#

ATMPs in Germany - Holoclar®

30.05.2024
Holoclar – the longest approved tissue engineered product that is still available in Germany...
#

ATMPs in Germany - Provenge®

30.05.2024
Provenge (active substance: sipuleucel-T) was approved for treatment of prostate cancer in September 2013....
#

ATMPs in Germany - MACI

08.05.2024
MACI was not assessed in German HTA because it was defined as being “part of a method” – this alters options for reimbursement...
#

ATMPs in Germany - Glybera®

02.05.2024
Glybera (active substance: alipogene tiparvovec) was approved for treatment of familial lipoprotein lipase deficiency (LPLD) in October 2012...
#

ATMPs in Germany - ChondroCelect®

24.04.2024
ChondroCelect® (characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins)...

 

Ansprechpartner

Ecker_Ecker-Koehnemann-RCP_3320.jpg

Dr. Florentin Köhnemann
Tel. +49 (40) 41 33 081-48